Article Text

Download PDFPDF

PhenX: Host: Social/Cognitive measures for tobacco regulatory research
Free
  1. Megan E Piper1,
  2. Darigg C Brown2,
  3. Tabitha P Hendershot2,
  4. Gary E Swan3
  5. PhenX TRR Host: Social/Cognitive Working Group
    1. 1 Center for Tobacco Research and Intervention, University of Wisconsin-Madison, Madison, Wisconsin, USA
    2. 2 RTI International, Research Triangle Park, North Carolina, USA
    3. 3 Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, California, USA
    1. Correspondence to Dr Megan E Piper, Center for Tobacco Research and Intervention, University of Wisconsin-Madison, Madison, WI 53711-2027, USA; MEP{at}ctri.wisc.edu

    Abstract

    A working group (WG) of experts from diverse fields related to nicotine and tobacco addiction was convened to identify elements and measures from the Host: Social/Cognitive domain to include in the Tobacco Regulatory Research Collection in the PhenX Toolkit, a catalogue of measures for biomedical research. This paper describes the methods used to identify, select, approve and include measures in the toolkit with potential relevance to users of both conventional and newer tobacco products, such as electronic cigarettes (e-cigarettes). In addition to 25 complementary measures primarily focused on cigarette use already present in the PhenX Toolkit, the WG recommended 11 additional social/cognitive measures focused on children and adult users or potential users of tobacco products. Of these, 10 were self-administered measures: frequency of communication with parents about smoking, quality of communication with parents about smoking, susceptibility to tobacco use, behaviour economics/purchase behaviour, motivation to quit (both single and multi-item measures), hedonic tone or response to pleasurable situations, multigroup ethnic identity, peer and family influence on smoking, attentional control and house rules about tobacco use. The remaining selected measure was computer based (distress tolerance). Although validated tools for use in the Host: Social/Cognitive realm are available, much remains to be done to develop, standardise and validate the tools for application to users of e-cigarettes and other non-combusted tobacco products, non-English language speakers and adolescents.

    • addiction
    • disparities
    • socioeconomic status

    Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors GES, TPH, and KLW led the conceptualisation of the manuscript and the coordination of the writing team. MEP and GES drafted the scientific content of the manuscript, and TPH and DCB drafted the Methods and Results sections of the manuscript. MEP, GES, TPH and KLW provided revisions. The Co-Chairs and Members of the PhenX TRR Host: Social/Cognitive Working Group identified and proposed preliminary measures, voted on final measures included in the PhenX TRR Host: Social/Cognitive Specialty Collection and reviewed the manuscript and provided substantive comments. TRR Panel members JJP and KLW ensured that the Working Group process maintained fidelity with overall project goals. Federal Agency Liaisons Sarah E Johnson, FDA Center for Tobacco Products and AK ensured project consistency with agency goals and priorities. NIH Project Coordinator KLW proposed the PhenX TRR initiative and contributed to its execution and completion. The PhenX team coordinated and facilitated the Working Group process, including project oversight and leadership (TPH), supervisory management (DCB) and project management (LK). Erin M Ramos, National Human Genome Research Institute, the PhenX NIH Program Official, provided project guidance and funding coordination. Carol M Hamilton, RTI International, is PhenX Principal Investigator and provided project guidance and supervision.

    • Funding Research reported in this publication was supported by grant numbers U41HG007050 and U41HG007050-01S1 from the NIH National Human Genome Research Institute and FDA Center for Tobacco Products.

    • Disclaimer The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Collaborators The following are members of the PhenX Tobacco Regulatory Research (TRR) Host: Social/Cognitive Working Group: Co-Chairs Thomas H Brandon, Moffitt Cancer Center, and Stephen T Tiffany, University at Buffalo; Working Group Members Laurie Chassin, Arizona State University, Pebbles Fagan, University of Arkansas for Medical Sciences and Megan Piper, University of Wisconsin-Madison; Special Consultant Bonnie Halpern-Felsher, Stanford University; TRR Panel Liaison Judith J Prochaska, Stanford University; TRR Panel Liaison and NIH Project Coordinator Kay L Wanke, NIH Office of Disease Prevention; NIH Liaison Annette Kaufman, National Cancer Institute; and the PhenX team from RTI International including Tabitha Hendershot, TRR RTI Project Lead, Darigg C Brown, WG Supervisor, and Lisa Kilpatrick, WG manager.